These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4215911)

  • 1. [Purification and application of tuberculosis adjuvants].
    Tanaka A
    Nihon Rinsho; 1974 Jul; 32(7):2518-25. PubMed ID: 4215911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Purification of an active adjuvant substance from Mycobacterium tuberculosis].
    Kumazawa Y; Mizunoe K
    Nihon Rinsho; 1974 Jul; 32(7):2509-13. PubMed ID: 4215910
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycobacterial adjuvant. I. Purification of an adjuvant-active component from wax D(H 37 Ra strain) by preparative thin-layer chromatography.
    Kumazawa Y; Tsushida A; Mizunoe K; Suzuki T; Kawanishi Y
    Jpn J Microbiol; 1972 Jan; 16(1):73-5. PubMed ID: 4625075
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of chemical and biological properties of water-soluble adjuvants prepared from Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium smegmatis.
    Kumazawa Y; Shibusawa A; Nakagawa N; Kojima Y; Mizunoe K
    Kitasato Arch Exp Med; 1976 Dec; 49(4):153-62. PubMed ID: 829910
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunochemical study of Mycobacteria firmly bound lipids.
    Hiu IJ; Amiel JL; Nikdjou K
    Rev Eur Etud Clin Biol; 1970 Oct; 15(8):887-91. PubMed ID: 4993152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological reactions induced by a lipopolysaccharide (wax D) of mycobacteria with special reference to adjuvant activity].
    Tanaka A
    Kekkaku; 1971 May; 46(3):41-51. PubMed ID: 4994699
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological adjuvants. II. Immunological activities of an adjuvant-active mycobacterial lipid, wax D, in the form of aqueous suspension.
    Shinozaki S; Tanaka A; Sugiyama K
    Int Arch Allergy Appl Immunol; 1969; 35(4):313-22. PubMed ID: 4976510
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on adjuvant activity of wax D fraction of mycobacteria].
    Someya S
    Kekkaku; 1968 Aug; 43(8):328-31. PubMed ID: 4974528
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance-enhancing compound from Mycobacterium tuberculosis.
    Hedgecock LW
    Am Rev Respir Dis; 1975 Nov; 112(5):633-8. PubMed ID: 811141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological reaction by wax D, a constituent of Mycobacterium tuberculosis].
    Tanaka A
    Kekkaku; 1972 Mar; 47(3):20-1. PubMed ID: 4113695
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological adjuvants. VI. An acetylated mycobacterial adjuvant lacking competing antigenicity.
    Tanaka A; Ishibashi T; Sugiyama K; Takamoto M
    Z Immunitatsforsch Exp Klin Immunol; 1971 Nov; 142(4):303-17. PubMed ID: 4257657
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analyses of biological responses to wax D, a component of tubercle bacilli].
    Tanaka A
    Kekkaku; 1972 Sep; 47(9):279-88. PubMed ID: 4630044
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental allergic encephalomyelitis in inbred and outbred mice.
    Levine S; Sowinski R
    J Immunol; 1973 Jan; 110(1):139-43. PubMed ID: 4631068
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological activities of hydrosoluble adjuvants of low molecular weight isolated from Mycobacterium tuberculosis var. hominis].
    Werner GH; Maral R; Floc'h F; Migliore-Samour D
    C R Acad Hebd Seances Acad Sci D; 1974 Feb; 278(6):789-92. PubMed ID: 4211317
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular commitments in delayed hypersensitivity.
    Raffel S
    Bibl Haematol; 1968; 29():647-52. PubMed ID: 4973301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tubercle bacilli and the infection theory].
    Yamamoto K
    Kekkaku; 1980 Oct; 55(10):457-61. PubMed ID: 6785509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipids of Mycobacterium tuberculosis and their biological properties].
    Stepanchenok-Rudnik GI
    Probl Tuberk; 1967; 45(1):83-6. PubMed ID: 4971664
    [No Abstract]   [Full Text] [Related]  

  • 18. The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.
    Chen L; Xu M; Wang ZY; Chen BW; Du WX; Su C; Shen XB; Zhao AH; Dong N; Wang YJ; Wang GZ
    FEMS Immunol Med Microbiol; 2010 Jun; 59(1):42-52. PubMed ID: 20298499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant and immunostimulating activities of water-soluble substances extracted from Mycobacterium tuberculosis (var. hominis).
    Werner GH; Maral R; Floch F; Migliore-Samour D; Jollès P
    Biomedicine; 1975 Sep; 22(5):440-52. PubMed ID: 4166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant activity and antigenicity of MAF3 determined by the lymphocyte blastogenesis (author's transl)].
    Kawamura Y; Kuazawa Y; Okada T; Morishita M; Mizunoe K
    Nihon Saikingaku Zasshi; 1978; 33(6):763-5. PubMed ID: 105172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.